Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Arbutus Biopharma Corp ABUS

Healthcare Biotechnology
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious disease. The Company is developing imdusiran (AB-729), its proprietary, conjugated GalNAc, subcutaneously delivered RNAi therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). Its HBV product pipeline includes Imdusiran and AB-101. Its... see more

Current News (NDAQ:ABUS)

Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025

GlobeNewswire October 7, 2025

Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire August 6, 2025

Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus

GlobeNewswire June 25, 2025

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire May 14, 2025

Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025

GlobeNewswire May 7, 2025

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025

GlobeNewswire April 23, 2025

Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

GlobeNewswire March 27, 2025

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

GlobeNewswire March 3, 2025

Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO

GlobeNewswire February 25, 2025
View More News ››

Opinion & Analysis (NDAQ:ABUS)

Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results

Streetwise Reports May 20, 2020

The Calandra Report: BioCryst Pharma, nothing to sneeze at

Thom Calandra October 15, 2014

Canadian Biotech comes back to life: A buyer's guide

Tony Pullen January 21, 2014
View More Opinion ››

Bullboard Posts (NDAQ:ABUS)

Arbutus Biopharma Corporation (NASDAQ:ABUS): Advancing Towar

http://beyondspx.com/2024/07/31/arbutus-biopharma-corporation-nasdaqabus-advancing-towards-a-functional-cure-for-chronic-hepatitis-b/
MikeTester - August 2, 2024

Time to put this puppy on the block....

Qilu or Moderna sound good.
hoffbag - January 11, 2022

Action these days!

Two big news stories at the same time - the win of an appeal on the patent challenge to Moderna and promising early results on the cHVB...
slithey - December 6, 2021

TKM

https://www.ctvnews.ca/health/coronavirus/how-the-early-work-of-a-canadian-scientist-and-his-team-made-the-covid-19-vaccines-possible-1...
zutfie - September 27, 2021

RE:Sleepy, quiet low float

Still sleepy and quiet....
hoffbag - April 2, 2021

RE:ABUS

Wow, another good news.
BelilieThun - July 26, 2020
View more Bullboard ››

Sekur Private Data Ltd.

Sekur Private Data Ltd.

Sekur Private Data Ltd. is a cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private ...
View More »